Also known as Exelon
Rivastigmine (sold under the trade name Exelon) is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer’s type and dementia due to Parkinson's disease. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting. The drug is eliminated through the urine, and appears to have relatively few drug-drug interactions.Source: Wikipedia
Estimated Total Cost: $204.32 for an average of 28 days supply
Patients are most commonly prescribed rivastigmine to treat alzheimer disease, disturbance of memory, delirium, and parkinson disease.